Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Glioblastoma
100%
Glioma Patients
88%
European Research
66%
Cancer Systems
66%
Systems Medicine
66%
Patient-derived Xenograft
66%
Brain Tumor Research
66%
Integrative multiomics
66%
Tumor
47%
Treatment Resistance
44%
Intratumoral Treatment
33%
Organoids
33%
Intratumoral Heterogeneity
33%
Single-cell RNA Sequencing (scRNA-seq)
33%
Patient Tumor
33%
Prefetcher
22%
Improved Patient Outcomes
22%
Tumor Microenvironment
16%
Novel Context
16%
Technological Approach
16%
Novel Therapeutics
14%
Temozolomide
14%
Brain Tumor
11%
Female Model
11%
Grade IV Glioma
11%
Adjuvant Radiochemotherapy
11%
Male Models
11%
Systemic Agents
11%
Surgical Adjuvants
11%
International Academics
11%
Disease Resistance Mechanism
11%
Innovative System
11%
Early-stage Researchers
11%
Intersectoral Research
11%
Disease Progression
11%
European Healthcare
11%
Data Integration
11%
Long-term Survivors
11%
Surgical Removal
11%
Gene mutation
11%
Molecular Analysis
11%
Blood-brain Barrier
11%
Glial Cells
11%
Innovative Therapies
11%
Multiple Signals
11%
MGMT Promoter Methylation
11%
Genome Analysis
11%
Omics Technologies
11%
Tumor Biology
11%
Drug Development
11%
Curative Treatment
11%
Surgical Resection
11%
Gender Analysis
11%
Unmet Needs
11%
Next-generation Sequencing Technology
11%
Healthcare Sector
11%
Clonal Evolution
11%
Economic Burden
11%
Resistant Cells
11%
Initial Performance
11%
Computational Modeling
11%
Innovative Research
11%
Signal Transduction Pathway
11%
Aggressive Treatment
11%
Specific Genes
11%
Clinical Datasets
11%
WHO Grade IV
11%
Performance Status
11%
Astrocytic Tumor
11%
Pathway-specific
11%
Treatment Costs
11%
Advisory Board
11%
Interdisciplinary Research
11%
Mechanistic Understanding
11%
Cell Clones
11%
Molecular Profiling
11%
Systems Biology
11%
Malignant Cells
11%
Tumor Incidence
11%
Brain Parenchyma
11%
Nervous System Tumors
11%
Treatment-resistant
11%
Brain Systems
11%
Computational System
11%
Proteogenomics
11%
Tumor Heterogeneity
11%
Young Female Patients
11%
Tumor-derived
11%
Medical Research Data
11%
Omics Dataset
11%
System Analysis
11%
Standard of Care
11%
Organoid Culture
11%
Preclinical Tool
11%
Tumor Organoids
11%
Drug Testing
11%
Intracranial Implants
11%
Orthotopic Xenograft Model
11%
Tumor Patients
11%
Functional Assay
11%
Cancer Research
11%
In Cancer
11%
Microglia
10%
Transcriptome
10%
Transcriptomic Adaptation
6%
Glioblastoma Tumor
6%
Phenotypic Plasticity
6%
Glioblastoma Cells
6%
Relevant Response
5%
Biochemistry, Genetics and Molecular Biology
Tamsulosin
66%
Genomics
66%
Multi-Omics
66%
Microglia
55%
Transcriptomics
44%
Clonal Evolution
44%
Promoter Region
44%
RNA Sequence
33%
Epidermal Growth Factor Receptor
33%
In Vivo Study
33%
Signal Transduction
33%
Next Generation Sequencing
33%
Clinical Research
33%
Methylation
33%
Cell Clone
33%
Glial Cells
33%
Gene Mutation
33%
Cancer Incidence
33%
Blood Brain Barrier
33%
Proteomics
33%
Computer Simulation
33%
Genetics
22%
IDH1
22%
Drug Development
16%
Vascularization
11%
Platelet Derived Growth Factor Receptor Alpha
11%
Clinical Trial
11%
Alpha Thalassemia/Mental Retardation X-Linked
11%
Phenotypic Plasticity
11%
Drug Response
11%
Cyclin-Dependent Kinase
11%
Cancer Model
11%
Cyclin Dependent Kinase Inhibitor 2A
11%
Rat
11%
Phagocytosis
5%
Tumor Escape
5%
Myeloid
5%
Cryopreservation
5%
Copurification
5%
Macrophage
5%
RNA Sequencing
5%
Cell Level
5%
Antigen Presentation
5%
Medicine and Dentistry
Cancer Research
75%
Glioblastoma
66%
Systems Medicine
66%
Malignant Neoplasm
66%
Intracranial Tumor
66%
Multi-Omics
66%
Tumor
58%
Ganglioglioma
41%
Organoid
33%
Xenograft
33%
Tamsulosin
16%
Clinician
16%
Diseases
16%
Genetics
16%
Neoplasm
8%
Temozolomide
8%
Tumor Biology
8%
Promoter Region
8%
Disease Resistance
8%
Nervous System Tumor
8%
Parenchyma
8%
Molecular Profiling
8%
Chemoradiotherapy
8%
Health Care Cost
8%
Disease Exacerbation
8%
Blood Brain Barrier
8%
Clinical Research
8%
Next Generation Sequencing
8%
Adjuvant
8%
Cancer Incidence
8%
Gene Mutation
8%
Somatics
8%
Signal Transduction Pathway
8%
Drug Screening
8%
Methylation
8%
Microglia
8%
Proteomics
8%
Surgery
8%